Private equity firms including Advent International, Apax Partners, Bain Capital, BC Partners, Blackstone Group, CVC Capital, Cinven and KKR have been named as potential bidders for the imminent sale of Netherlands food group Vion’s ingredients arm, according to Reuters.
The sale could make between €1.4bn and over €2bn, it said.
Vion Ingredients utilises products from slaughter by-product markets used as pharmaceutics, cosmetics, food, feed, energy and technology. It is the global market leader for gelatine, and invests in the production of biofuel and biophosphates.
Bank of America Merrill Lynch is managing the sale and could offer a staple financing for the deal.
A Vion spokesman told Reuters: “There is great interest in our Ingredients activities, both from business players as well as private equity. We expect the sales process to be realised by the end of the year.”
Debt packages could amount to €700m to €1bn in both leveraged loans and high yield bonds.
Copyright © 2013 AltAssets